Alphamab Oncology
HKEX:9966.HK
3.87 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||
| Net Income
| -210.593 | -325.722 | -412.417 | -427.766 | -832.74 | -202.633 | -64.826 |
| Depreciation & Amortization
| 69.118 | 55.188 | 41.102 | 30.127 | 11.773 | 6.562 | 0.514 |
| Deferred Income Tax
| 0 | 1.32 | 13.025 | -14.324 | 0.106 | -0.263 | -0.192 |
| Stock Based Compensation
| 15.381 | 13.292 | 8.168 | 32.727 | 91.023 | 0.263 | 0.192 |
| Change In Working Capital
| 8.009 | -14.612 | -21.193 | -18.403 | -12.204 | -3.325 | -0.652 |
| Accounts Receivables
| 8.359 | -7.884 | -7.606 | 0 | -33.179 | -17.04 | -3.589 |
| Inventory
| -14.111 | -6.728 | -13.587 | -18.403 | -18.85 | -3.582 | -3.121 |
| Accounts Payables
| 0 | -21.137 | 1.252 | 0 | 33.179 | 17.04 | 3.589 |
| Other Working Capital
| 15.547 | 21.137 | -1.252 | -16.78 | 6.646 | 0.257 | 6.058 |
| Other Non Cash Items
| -64.095 | -29.774 | 50.715 | 50.459 | 516.545 | 105.522 | -0.389 |
| Operating Cash Flow
| -202.839 | -300.308 | -320.6 | -347.18 | -225.497 | -93.874 | -65.161 |
| Investing Activities: | |||||||
| Investments In Property Plant And Equipment
| -36.184 | -129.651 | -158.119 | -90.822 | -171.373 | -73.118 | -8.35 |
| Acquisitions Net
| 0 | -942.057 | -675.216 | 1,462.934 | 0 | 0 | 0 |
| Purchases Of Investments
| -638.716 | -1,233.975 | -1,569.702 | -2,460.44 | -1,149.109 | -48.9 | -34 |
| Sales Maturities Of Investments
| 599.194 | 2,176.032 | 2,244.918 | 997.506 | 647.102 | 49.5 | 44.45 |
| Other Investing Activites
| 18.077 | 980.407 | 732.383 | -1,432.861 | 19.367 | 0.408 | 0.205 |
| Investing Cash Flow
| -18.107 | 850.756 | 574.264 | -1,523.683 | -654.013 | -72.11 | 2.305 |
| Financing Activities: | |||||||
| Debt Repayment
| -75 | -692.952 | -313.971 | -141.506 | -12.685 | -67.526 | 0 |
| Common Stock Issued
| 321.034 | 0.253 | 0.345 | 250.258 | 1,646.188 | 0.007 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 305.964 | 381.797 | 677.528 | 77.827 | 480.078 | 866.319 | 2 |
| Financing Cash Flow
| 218.072 | -310.902 | 363.902 | 186.579 | 2,113.581 | 798.8 | 2 |
| Other Information: | |||||||
| Effect Of Forex Changes On Cash
| 19.673 | 26.337 | 0.419 | 1.739 | -0.316 | -8.698 | 60.868 |
| Net Change In Cash
| 16.799 | 265.883 | 617.985 | -1,682.545 | 1,234.154 | 633.655 | 0.012 |
| Cash At End Of Period
| 1,085.988 | 1,069.189 | 803.306 | 185.321 | 1,867.866 | 633.712 | 0.057 |